Author avatar

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2025-05-03 17:24:08

Metals at the Host–Fungal Pathogen Battleground

Fungal pathogens rely on metal acquisition for virulence. This review reveals how host tissues manipulate iron, copper, zinc, and manganese to starve or intoxicate fungi and how pathogens adapt, with implications for antifungal therapy and microbiome-targeted interventions.

2025-05-03 17:08:35

Role of Nickel in Microbial Pathogenesis

Nickel-dependent enzymes like urease and hydrogenase are essential for pathogen virulence. This review outlines the mechanisms by which pathogens acquire and utilize nickel and explores implications for therapy and microbiome balance.

2025-04-28 17:30:49

Metformin

Metformin is a synthetic derivative of guanidine derived from the guanidine alkaloid of the plant Galega officinalis L. with significant hypoglycemic effects. It is a first-line antihyperglycemic agent due to its efficacy, low cost, and favorable safety profile.

2025-04-02 09:24:38

Metallomics in Neurodegenerative Diseases: A mini-review

This review highlights how neurodegenerative diseases like Alzheimer’s disease (D), Parkinson’s disease (D), and dementia with Lewy bodies (LB) exhibit disease-specific metallomic signatures, with copper depletion as a shared feature. Metal imbalances reflect both cause and consequence in neurodegeneration and may offer diagnostic potential when captured through region-specific elemental analysis.

2025-04-01 14:10:00

Metallomic signatures of brain tissues distinguishes between cases of dementia with Lewy bodies, Alzheimer’s disease, and Parkinson’s disease dementia

Dementia with Lewy bodies (LB) brains show widespread copper depletion and region-specific sodium, manganese, iron, and selenium alterations. While copper loss is common to D and DD, LB presents a distinct metallomic fingerprint, enabling disease differentiation via CA. Metallomic profiling may aid in diagnosing overlapping dementias and reveals unique pathophysiological signatures.

2025-03-27 13:55:37

Urine metallomics signature as an indicator of pancreatic cancer†

This study identifies a distinct urinary metallomic signature in pancreatic cancer patients, marked by altered calcium, magnesium, copper, and zinc levels, along with lighter zinc isotopic composition. These findings suggest that non-invasive urine tests could enable early DAC detection by leveraging trace metal imbalances and stable isotope shifts.

2025-03-27 13:13:56

Metallomic Signatures

A metallomic signature is the condition-specific profile of trace metals and metal-binding molecules that reflects disrupted metal homeostasis.

2025-03-22 08:58:17

Facultative Anaerobes

Facultative anaerobes are microorganisms—primarily bacteria—that possess the metabolic flexibility to grow in both the presence and absence of oxygen.